Kimberlee C Drapkin is of YUMANITY THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of YMTX, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2025, when has been sold 13,794 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Kimberlee C Drapkin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2025
SELL
Sale (or disposition) back to the issuer
-
13,794 Reduced 100.0%
0 Common Stock
Jun 25 2025
BUY
Grant, award, or other acquisition
-
6,000 Added 30.31%
13,794 Common Stock
Jun 23 2025
SELL
Payment of exercise price or tax liability
$1,223 $0.26 p/Share
4,706 Reduced 37.65%
7,794 Common Stock
Jun 23 2025
BUY
Exercise of conversion of derivative security
$7,625 $0.61 p/Share
12,500 Added 50.0%
12,500 Common Stock

Also insider at

JNCE
Jounce Therapeutics, Inc. Healthcare
ABOS
Acumen Pharmaceuticals, Inc. Healthcare
GRPH
Graphite Bio, Inc. Healthcare
ELYM
Eliem Therapeutics, Inc. Healthcare
KCD

Kimberlee C Drapkin

Cambridge, MA

Track Institutional and Insider Activities on YMTX

Follow YUMANITY THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMTX shares.

Notify only if

Insider Trading

Get notified when an Yumanity Therapeutics, Inc. insider buys or sells YMTX shares.

Notify only if

News

Receive news related to YUMANITY THERAPEUTICS, INC.

Track Activities on YMTX